Retail Clinics

  • Former MinuteClinic exec shifts to Santa Rosa Community Health Centers

    SANTA ROSA, Calif. Former MinuteClinic regional medical director Francisco Trilla has joined Santa Rosa Community Health Centers, according to local news reports.

    Trilla will serve as the new chief medical officer of Santa Rosa Community Health Centers, overseeing clinical programs at all of its eight facilities with "an emphasis on access and quality," according to reports.

  • Study: Patients increasingly turn to ER for acute ailments

    NEW YORK Millions of patients with such acute ailments as fevers and coughs turn to the emergency room for treatment, according to researchers. The findings serve as yet one more indicator for the need of convenient and affordable health services available at retail-based clinics.

  • Target opens eight new clinics

    MINNEAPOLIS Target officially announced on Monday the opening of eight new Target Clinic locations in Chicago and the Palm Beach, Fla., area.

    "Health and wellness is an important focus for Target, and we're thrilled to offer Target Clinic services to our guests in Chicago and the Palm Beach area," stated Keri Jones, SVP merchandising for Target. "We hope the new locations help our guests and their families reach their well-being goals with the same quality of service and value they expect from Target."

  • Bayer Consumer Care adds two products to One A Day line

    MORRISTOWN, N.J. Bayer Consumer Care on Tuesday introduced two new gender-specific multivitamins: One A Day Menopause Formula and One A Day Men’s Pro Edge.

     

    One A Day Menopause Formula is a complete multivitamin formulated with soy isoflavones to help address hot flashes and mild mood changes.

     

  • Teva markets AcuDial generic

    NORTH WALES, Pa. Teva Pharmaceuticals has launched a generic treatment for epileptic seizures.

     

    The world’s largest generic drug maker announced Wednesday the launch of diazepam rectal gel, a generic version of Valeant Pharmaceuticals’ Diastat AcuDial. The drug is administered via rectal syringe and is available in 2.5-mg, 10-mg and 20-mg strengths.

     

     

  • FDA to discuss concerns over medicines with DXM

    SILVER SPRING, Md. The Food and Drug Administration last week issued an information packet in preparation for a Sept. 14 advisory committee meeting that will address the potential abuse of dextromethorphan products and whether restrictions should be placed on the sale of those over-the-counter cough medicines.

     

    Members of both the FDA Drug Safety and Risk Management Advisory Committee and the FDA Nonprescription Drugs Advisory Committee will be in attendance at the public meeting.

     

     

  • Allergan's elevated intraocular pressure treatment gets nod from FDA

    IRVINE, Calif. Allergan's optimized reformulation of Lumigan has received approval from the Food and Drug Administration, the drug maker said Wednesday.

    Lumigan 0.01% (bimatoprost ophthalmic solution) is a first-line therapy indicated for the reduction of elevated intraocular pressure with open-angle glaucoma or ocular hypertension, Allergan said. Lumigan 0.01% will be available in fourth quarter 2010 as the newest addition to Allergan’s comprehensive glaucoma portfolio.

     

  • Target looks to expand clinic business

    MINNEAPOLIS Target is looking to open eight new Target Clinic locations in Chicago and Palm Beach, Fla., in September.

    Target currently has 28 clinics in Minnesota and Maryland, according to the website. The healthcare services in Minnesota and Maryland are provided by Target Clinic Medical Associates, an unaffiliated corporation not owned or operated by Target Corp. Fees for most services range from $59 to $69.

  • 'Multifaceted strategies' can improve medication adherence among patients

    SAN DIEGO Improving medication adherence will require bringing multiple methods together in order to be successful, Pharmacy Quality Alliance senior director for research and performance measurement David Nau said Tuesday in an education session at the National Association of Chain Drug Stores’ Pharmacy and Technology Conference in San Diego.

     

    “You need to have a multifaceted strategy around adherence if you want to have an impact on adherence,” Nau said.

     

     

  • Study: SAMe may benefit patients taking antidepressants

    BOSTON A new study conducted by investigators at Harvard Medical School and Massachusetts General Hospital suggested that the dietary supplement S-adenosylmethionine (SAMe) can be an effective, relatively well-tolerated, adjunctive treatment for adults with major depressive disorders who do not respond to their treatment with antidepressant medication, Pharmavite announced Tuesday.

X
This ad will auto-close in 10 seconds